Yuxing Hu

808 total citations
49 papers, 532 citations indexed

About

Yuxing Hu is a scholar working on Oncology, Molecular Biology and Immunology. According to data from OpenAlex, Yuxing Hu has authored 49 papers receiving a total of 532 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 12 papers in Molecular Biology and 10 papers in Immunology. Recurrent topics in Yuxing Hu's work include Immunotherapy and Immune Responses (6 papers), CAR-T cell therapy research (6 papers) and Immune Cell Function and Interaction (5 papers). Yuxing Hu is often cited by papers focused on Immunotherapy and Immune Responses (6 papers), CAR-T cell therapy research (6 papers) and Immune Cell Function and Interaction (5 papers). Yuxing Hu collaborates with scholars based in China, Belgium and Denmark. Yuxing Hu's co-authors include Yuhua Li, Xiaoling Xie, Yanjie He, Honghao Zhang, Wei Wei, Guanghui Ma, Honghong Chen, Jianyu Chen, Xiaoyong Gao and Shuang Wang and has published in prestigious journals such as Advanced Materials, Blood and Nature Nanotechnology.

In The Last Decade

Yuxing Hu

45 papers receiving 525 citations

Peers

Yuxing Hu
Feng Qiu China
Tao Jing China
Xinyao Li China
Feng Qiu China
Yuxing Hu
Citations per year, relative to Yuxing Hu Yuxing Hu (= 1×) peers Feng Qiu

Countries citing papers authored by Yuxing Hu

Since Specialization
Citations

This map shows the geographic impact of Yuxing Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuxing Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuxing Hu more than expected).

Fields of papers citing papers by Yuxing Hu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuxing Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuxing Hu. The network helps show where Yuxing Hu may publish in the future.

Co-authorship network of co-authors of Yuxing Hu

This figure shows the co-authorship network connecting the top 25 collaborators of Yuxing Hu. A scholar is included among the top collaborators of Yuxing Hu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuxing Hu. Yuxing Hu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ding, Donghai, Yuxing Hu, Guoqing Xiao, et al.. (2025). Catalytic combustion synthesis of MgO@C nanochains composite powders and the influences on the conductivity of carbon/ceramic composites. Journal of Materials Science Materials in Electronics. 36(5).
2.
Chen, Jianyu, Rong Hu, Honghao Zhang, et al.. (2025). Administration of lipid nanoparticle-encapsulated mRNA encoding CCR7, CXCL16 and GITRL effectively mobilizes antitumor T cell immunity. International Journal of Biological Macromolecules. 318(Pt 1). 144766–144766.
3.
4.
Hu, Yuxing, et al.. (2024). Walk or not? Effectiveness of walking on the immune level in residential outdoor space in severely cold regions. Building and Environment. 270. 112486–112486.
5.
Zhou, Junming, Yuxing Hu, Xiaofeng Niu, et al.. (2024). Conjugate heat and mass transfer in vacuum membrane distillation for solution regeneration using hollow fiber membranes. Applied Thermal Engineering. 241. 122346–122346. 10 indexed citations
6.
Zhang, Honghao, Jianyu Chen, Hao Wang, et al.. (2024). Overexpression of Pin1 regulated by TOP2A, which subsequently stabilizes Pyk2 to promote bortezomib resistance in multiple myeloma. Cancer Gene Therapy. 32(1). 22–37. 2 indexed citations
7.
Zhang, Honghao, Hao Wang, Yuxing Hu, et al.. (2024). Targeting PARP14 with lomitapide suppresses drug resistance through the activation of DRP1-induced mitophagy in multiple myeloma. Cancer Letters. 588. 216802–216802. 11 indexed citations
9.
Chang, Ning, et al.. (2023). Knockdown of MEF2D inhibits the development and progression of B-cell acute lymphoblastic leukemia. Translational Cancer Research. 12(2). 287–300. 4 indexed citations
10.
Xie, Xiaoling, Xuan Zhou, Hao Wang, et al.. (2023). Low doses of IFN-γ maintain self-renewal of leukemia stem cells in acute myeloid leukemia. Oncogene. 42(50). 3657–3669. 8 indexed citations
11.
Hu, Yuxing, et al.. (2023). Unraveling bacterial and eukaryotic communities in secondary water supply systems: Dynamics, assembly, and health implications. Water Research. 245. 120597–120597. 16 indexed citations
12.
Yang, Jin‐Hao, et al.. (2023). Deciphering the diversity and assemblage mechanisms of nontuberculous mycobacteria community in four drinking water distribution systems with different disinfectants. The Science of The Total Environment. 907. 168176–168176. 6 indexed citations
13.
Zhou, Junming, et al.. (2023). Personal Wearable Thermal and Moisture Management Clothing: A Review on Its Recent Trends and Performance Evaluation Methods. Processes. 11(11). 3063–3063. 7 indexed citations
14.
Wang, Changlong, Wei Zhang, Yanjie He, et al.. (2021). Ferritin-based targeted delivery of arsenic to diverse leukaemia types confers strong anti-leukaemia therapeutic effects. Nature Nanotechnology. 16(12). 1413–1423. 76 indexed citations
15.
Xie, Xiaoling, Yuxing Hu, Tong Ye, et al.. (2021). Author Correction: Therapeutic vaccination against leukaemia via the sustained release of co-encapsulated anti-PD-1 and a leukaemia-associated antigen. Nature Biomedical Engineering. 5(5). 482–482. 1 indexed citations
16.
Deng, Zhe, Qing Zhou, Yuxing Hu, et al.. (2021). Shuyu pills inhibit immune escape and enhance chemosensitization in hepatocellular carcinoma. World Journal of Gastrointestinal Oncology. 13(11). 1725–1740. 9 indexed citations
17.
Xie, Xiaoling, et al.. (2019). Lenalidomide Augments the Antitumor Activities of Eps8 Peptide-Specific Cytotoxic T Lymphocytes against Multiple Myeloma. Molecular Cancer Therapeutics. 18(12). 2258–2269. 6 indexed citations
19.
Bao, Yizhong, Dan Wang, Zhiming Li, et al.. (2013). Efficacy of a novel chelator BPCBG for removing uranium and protecting against uranium-induced renal cell damage in rats and HK-2 cells. Toxicology and Applied Pharmacology. 269(1). 17–24. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026